Vildagliptin + Metformin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: Vildagliptin 50 mg + Metformin 500 mg/850mg/1000mg
Reference Brands: Galvus Met (EU)
Category:
Diabetes
Vildagliptin inhibits DPP-4, increasing incretin hormones (GLP-1, GIP) to boost insulin secretion and suppress glucagon. Metformin reduces hepatic glucose output and improves insulin sensitivity. Together, they offer synergistic glucose control, reduced HbA1c, and a lower risk of hypoglycemia or weight gain. Ideal for managing type 2 diabetes with dual action.
Vildagliptin + Metformin Tablets is available in Tablets
and strengths such as Vildagliptin 50 mg + Metformin 500 mg/850mg/1000mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vildagliptin + Metformin Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vildagliptin + Metformin Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Vildagliptin and Metformin combination tablets are approved in the European Union under brand names like Galvus Met, Eucreas, and Icandra. These are indicated for the treatment of type 2 diabetes mellitus in adults when diet, exercise, and monotherapy do not provide adequate glycemic control. The product is regulated by the European Medicines Agency (EMA) and follows strict pharmacovigilance and quality standards. As of now, no FDA approval exists for Vildagliptin in the USA, limiting its availability. Manufacturers must comply with EU GMP standards and labeling requirements. Pharmatradz.com facilitates sourcing EU-approved diabetic formulations globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing